Redefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of Mrgprs
暂无分享,去创建一个
Ehsan Azimi | Xinzhong Dong | Shuohao Sun | Xinzhong Dong | Vemuri B. Reddy | Shuohao Sun | Sarina B. Elmariah | Ethan A. Lerner | E. Lerner | E. Azimi | S. Elmariah | V. B. Reddy
[1] David J. Anderson,et al. A Diverse Family of GPCRs Expressed in Specific Subsets of Nociceptive Sensory Neurons , 2001, Cell.
[2] J. Vilardaga. ENDOSOMAL GENERATION OF cAMP in GPCR SIGNALING , 2014, Nature chemical biology.
[3] S. Bevan,et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.
[4] E. Lerner,et al. Plant cysteine proteases that evoke itch activate protease‐activated receptors , 2010, The British journal of dermatology.
[5] G. Bilbe,et al. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.
[6] D. Banville,et al. Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs , 2002, Nature Neuroscience.
[7] P. Nurden,et al. The Cleaved Peptide of PAR1 Results in a Redistribution of the Platelet Surface GPIb-IX-V Complex to the Surface-Connected Canalicular System , 2000, Thrombosis and Haemostasis.
[8] Xinzhong Dong,et al. TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch , 2011, Nature Neuroscience.
[9] K. Hoffmann,et al. Upregulation of cathepsin S in psoriatic keratinocytes , 2009, Experimental dermatology.
[10] Hollenberg. Proteinases and signalling - to PAR or Bogey: Pathophysiological and therapeutic implications via PARs and more , 2007 .
[11] Ping-Chang Yang,et al. Mast Cell Tryptase Controls Paracellular Permeability of the Intestine , 2005, Journal of Biological Chemistry.
[12] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[13] M. Bogyo,et al. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice. , 2011, Gastroenterology.
[14] R. LaMotte,et al. Mechanisms of Itch Evoked by β-Alanine , 2012, The Journal of Neuroscience.
[15] T. Lotti,et al. Itch in psoriasis: epidemiology, clinical aspects and treatment options , 2009, Clinical, cosmetic and investigational dermatology.
[16] M. von Zastrow,et al. G Protein-coupled Receptor (GPCR) Signaling via Heterotrimeric G Proteins from Endosomes* , 2015, The Journal of Biological Chemistry.
[17] Xinzhong Dong,et al. The Distinct Roles of Two GPCRs, MrgprC11 and PAR2, in Itch and Hyperalgesia , 2011, Science Signaling.
[18] E. Lerner,et al. Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist , 2014, PloS one.
[19] R. Dubner,et al. Central Terminal Sensitization of TRPV1 by Descending Serotonergic Facilitation Modulates Chronic Pain , 2014, Neuron.
[20] 김나리,et al. Overexpression of cathepsin S induces chronic atopic dermatitis in mice , 2011 .
[21] HighWire Press. The journal of neuroscience : the official journal of the Society for Neuroscience. , 1981 .
[22] M. Pellegrino,et al. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch , 2013, Cell.
[23] J. Wallace,et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.
[24] C. Flordellis,et al. Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis , 2009, Journal of Pharmacology and Experimental Therapeutics.
[25] Erik Lindström,et al. Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4* , 2014, The Journal of Biological Chemistry.
[26] R. LaMotte,et al. Cathepsin S elicits itch and signals via protease-activated receptors. , 2010, The Journal of investigative dermatology.
[27] R. LaMotte,et al. BAM8–22 Peptide Produces Itch and Nociceptive Sensations in Humans Independent of Histamine Release , 2011, The Journal of Neuroscience.
[28] Bonnie F. Sloane,et al. Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.
[29] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[30] Robert H. LaMotte,et al. Cowhage-Evoked Itch Is Mediated by a Novel Cysteine Protease: A Ligand of Protease-Activated Receptors , 2008, The Journal of Neuroscience.
[31] David J. Anderson,et al. Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus , 2009, Cell.
[32] N. Schork,et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. , 1988, Archives of dermatology.
[33] M. Bayliss,et al. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups , 2009, Health and quality of life outcomes.
[34] R. LaMotte,et al. Behavioral differentiation between itch and pain in mouse , 2008, PAIN.
[35] M. Hollenberg,et al. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more , 2008, British journal of pharmacology.
[36] Christopher M. Tan,et al. Genetic and pharmacological evaluation of cathepsin s in a mouse model of asthma. , 2011, American journal of respiratory cell and molecular biology.
[37] A. Ray,et al. Cysteine cathepsin S as an immunomodulatory target: present and future trends , 2008, Expert opinion on therapeutic targets.
[38] Alex Bateman,et al. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors , 2011, Nucleic Acids Res..